Aurel Perren

24.8k total citations · 11 hit papers
259 papers, 15.6k citations indexed

About

Aurel Perren is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Aurel Perren has authored 259 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Epidemiology, 141 papers in Oncology and 89 papers in Neurology. Recurrent topics in Aurel Perren's work include Neuroendocrine Tumor Research Advances (146 papers), Neuroblastoma Research and Treatments (88 papers) and Lung Cancer Research Studies (85 papers). Aurel Perren is often cited by papers focused on Neuroendocrine Tumor Research Advances (146 papers), Neuroblastoma Research and Treatments (88 papers) and Lung Cancer Research Studies (85 papers). Aurel Perren collaborates with scholars based in Switzerland, Germany and United States. Aurel Perren's co-authors include Paul Komminoth, Günter Klöppel, Philipp U. Heitz, Kjell Öberg, Martin Anlauf, Guido Rindi, Anja Schmitt, Bertram Wiedenmann, Aldo Scarpa and Anne Couvelard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Aurel Perren

248 papers receiving 15.3k citations

Hit Papers

TNM staging of foregut (neuro)endocrine tumors: a consens... 2004 2026 2011 2018 2006 2007 2020 2007 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
    2006 1.2k citations Guido Rindi, Martyn Caplin et al. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin profile →
  2. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
    2007 693 citations Guido Rindi, Günter Klöppel et al. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin profile →
  3. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2020 653 citations Aurel Perren et al. profile →
  4. Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
    2007 613 citations Aurel Perren et al. profile →
  5. The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
    2004 583 citations Günter Klöppel, Aurel Perren et al. profile →
  6. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
    2016 403 citations Rocio García‐Carbonero, Halfdan Sørbye et al. Neuroendocrinology profile →
  7. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2012 380 citations Aurel Perren et al. profile →
  8. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
    2016 315 citations Bruno Niederle, Aurel Perren et al. Neuroendocrinology profile →
  9. Overview of the 2022 WHO Classification of Parathyroid Tumors
    2022 133 citations Aurel Perren et al. Endocrine Pathology profile →
  10. European Neuroendocrine Tumour Society ( ENETS ) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
    2023 96 citations Justo P. Castaño, Stefano Partelli et al. Journal of Neuroendocrinology profile →
  11. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
    2023 95 citations Massimo Falconi, Emanuel Christ et al. Journal of Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurel Perren Switzerland 62 9.8k 9.3k 5.9k 3.1k 2.7k 259 15.6k
Jean‐Yves Scoazec France 73 7.2k 0.7× 7.8k 0.8× 3.2k 0.5× 4.3k 1.4× 4.2k 1.6× 507 19.0k
Gianfranco Delle Fave Italy 56 8.0k 0.8× 7.5k 0.8× 4.5k 0.8× 2.9k 0.9× 1.4k 0.5× 258 12.0k
Manisha H. Shah United States 53 4.8k 0.5× 7.7k 0.8× 3.1k 0.5× 2.4k 0.8× 4.3k 1.6× 203 18.0k
Philippe Ruszniewski France 78 15.5k 1.6× 17.6k 1.9× 9.5k 1.6× 6.2k 2.0× 1.6k 0.6× 426 22.9k
Larry K. Kvols United States 63 10.2k 1.0× 9.2k 1.0× 7.3k 1.3× 1.5k 0.5× 1.0k 0.4× 225 13.8k
Günter Klöppel Germany 92 13.1k 1.3× 19.7k 2.1× 5.6k 1.0× 13.1k 4.3× 5.9k 2.2× 457 30.6k
Samuel A. Wells United States 62 4.1k 0.4× 4.7k 0.5× 1.6k 0.3× 3.9k 1.3× 3.7k 1.4× 256 16.2k
David Schiff United States 69 2.7k 0.3× 2.8k 0.3× 3.3k 0.6× 2.4k 0.8× 4.5k 1.7× 373 16.9k
Masayuki Imamura Japan 64 2.7k 0.3× 5.9k 0.6× 1.1k 0.2× 3.1k 1.0× 5.1k 1.9× 355 13.3k
Meinoshin Okumura Japan 55 1.9k 0.2× 2.4k 0.3× 3.1k 0.5× 2.4k 0.8× 1.5k 0.6× 346 10.3k

Countries citing papers authored by Aurel Perren

Since Specialization
Citations

This map shows the geographic impact of Aurel Perren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurel Perren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurel Perren more than expected).

Fields of papers citing papers by Aurel Perren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurel Perren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurel Perren. The network helps show where Aurel Perren may publish in the future.

Co-authorship network of co-authors of Aurel Perren

This figure shows the co-authorship network connecting the top 25 collaborators of Aurel Perren. A scholar is included among the top collaborators of Aurel Perren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurel Perren. Aurel Perren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tacelli, Matteo, Manuel Gentiluomo, Justo P. Castaño, et al.. (2025). Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis. Seminars in Cancer Biology. 112. 112–125. 3 indexed citations
2.
Sørbye, Halfdan, Geir Olav Hjortland, Anna Sundlöv, et al.. (2024). NETest in advanced high‐grade gastroenteropancreatic neuroendocrine neoplasms. Journal of Neuroendocrinology. 36(11). e13428–e13428. 3 indexed citations
3.
Neels, A., et al.. (2024). 3D Virtual Histopathology by Phase-Contrast X-Ray Micro-CT for Follicular Thyroid Neoplasms. IEEE Transactions on Medical Imaging. 43(7). 2670–2678. 7 indexed citations
4.
Berezowska, Sabina, et al.. (2023). Impact of template-based synoptic reporting on completeness of surgical pathology reports. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(1). 31–36. 7 indexed citations
5.
Christ, Emanuel, Donato Iacovazzo, Márta Korbonits, & Aurel Perren. (2023). Insulinomatosis: new aspects. Endocrine Related Cancer. 30(6). 6 indexed citations
6.
Dettmer, Matthias S., et al.. (2023). Cribriform Morular Thyroid Carcinoma – Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case. Endocrine Pathology. 34(3). 342–348. 3 indexed citations
7.
Merola, Elettra, Aurel Perren, Anja Rinke, et al.. (2022). High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent. Journal of Neuroendocrinology. 34(10). e13193–e13193. 9 indexed citations
8.
April-Monn, Simon, Daniel Helbling, Massimo Falconi, et al.. (2022). Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers. 14(22). 5481–5481. 5 indexed citations
9.
Partelli, Stefano, Valentina Andreasi, Ilaria Marinoni, et al.. (2022). Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Surgery. 172(4). 1236–1244. 16 indexed citations
10.
Velthuysen, Marie‐Louise F. van, Anne Couvelard, Guido Rindi, et al.. (2022). ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology. Journal of Neuroendocrinology. 34(3). e13100–e13100. 15 indexed citations
11.
Saghafinia, Sadegh, Krisztián Homicskó, Annunziata Di Domenico, et al.. (2021). Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression. Cancer Discovery. 11(10). 2638–2657. 29 indexed citations
12.
Rinke, Anja, Christoph J. Auernhammer, Lisa Bodei, et al.. (2021). Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?. Gut. 70(9). 1768–1781. 24 indexed citations
13.
Liu, He, Zhaoyue He, Nina Germič, et al.. (2019). ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics. Cell Death and Differentiation. 27(6). 1965–1980. 24 indexed citations
14.
Weyerer, Veronika, Evgeny A. Moskalev, Florian Haller, et al.. (2019). Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma. Histopathology. 75(6). 865–875. 29 indexed citations
15.
Wiedmer, Tabea, Annika Blank, Ruben Bill, et al.. (2017). Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism. Molecular Cancer Therapeutics. 16(11). 2502–2515. 55 indexed citations
16.
García‐Carbonero, Rocio, Halfdan Sørbye, Éric Baudin, et al.. (2016). ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Neuroendocrinology. 103(2). 186–194. 403 indexed citations breakdown →
17.
Hermann, Gratiana, Björn Konukiewitz, Anja Schmitt, Aurel Perren, & Günter Klöppel. (2011). Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 459(2). 147–154. 53 indexed citations
18.
19.
Barghorn, André, Ernst‐Jan M. Speel, Parvin Saremaslani, et al.. (2001). Putative Tumor Suppressor Loci at 6q22 and 6q23-q24 Are Involved in the Malignant Progression of Sporadic Endocrine Pancreatic Tumors. American Journal Of Pathology. 158(6). 1903–1911. 70 indexed citations
20.
Perren, Aurel, Alexander H. Boag, Patricia L. M. Dahia, et al.. (1999). Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast. American Journal Of Pathology. 155(4). 1253–1260. 327 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Yves Scoazec Breakdown of academic impact, for papers by Gianfranco Delle Fave Breakdown of academic impact, for papers by Manisha H. Shah Breakdown of academic impact, for papers by Philippe Ruszniewski Breakdown of academic impact, for papers by Larry K. Kvols Breakdown of academic impact, for papers by Günter Klöppel Breakdown of academic impact, for papers by Samuel A. Wells Breakdown of academic impact, for papers by David Schiff Breakdown of academic impact, for papers by Masayuki Imamura Breakdown of academic impact, for papers by Meinoshin Okumura
Rankless by CCL
2026